Journals / Nöropsikiyatri Arşivi / 2018 / Cilt: 55 - Sayı: 1

Factors Associated with Early Recovery after Intravenous Thrombolytic Therapy in Acute Ischemic Stroke

Akut İskemik İnmede İntravenöz Trombolitik Tedavi Sonrası Erken Dönem Tam İyileşme ile İlişkili Faktörler

Pages
80–83
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therefore, the management of factors such as serum glucose level, NIHSS score, ASPECT score and presence of hyperdense artery sign which are related to ENI, and the determination of treatment strategies according to them are important issues for achieving a better outcome in acute ischemic stroke.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: In this study, we aimed to identify the factors associated with early neurological improvement (ENI) in acute stroke patients treated with intravenous recombinant tissue plasminogen activator (IV rt-PA), and to determine the association between ENI and outcomes at 3 months after stroke.
📊
Key Findings & Data:Methods: Patients with acute ischemic stroke who were treated with IV rt-PA within 4.5 hours of symptom onset from February 2009 to December 2016 were included in the study at the stroke center of Eskişehir Osmangazi University Medical Faculty.
💡
Conclusion & Impact:Therefore, the management of factors such as serum glucose level, NIHSS score, ASPECT score and presence of hyperdense artery sign which are related to ENI, and the determination of treatment strategies according to them are important issues for achieving a better outcome in acute ischemic stroke.
🔬Design:Research Article
📍Scope:2009 Verileri
⚙️Variables:Domain Parameters

Abstract

Introduction: In this study, we aimed to identify the factors associated with early neurological improvement (ENI) in acute stroke patients treated with intravenous recombinant tissue plasminogen activator (IV rt-PA), and to determine the association between ENI and outcomes at 3 months after stroke. Methods: Patients with acute ischemic stroke who were treated with IV rt-PA within 4.5 hours of symptom onset from February 2009 to December 2016 were included in the study at the stroke center of Eskişehir Osmangazi University Medical Faculty. ENI was defined as an improvement in National Institutes of Health Stroke Scale (NIHSS) score of ≥8 points compared to the pretreatment score or an NIHSS score of 0 or 1 at 24 hours after stroke. We assessed the outcomes at 3 months after treatment using the modified Rankin Scale (mRS) score, and mRS scores of 0–1 were defined as ‘very good’ outcomes. Results: ENI was observed in 43.9% of 355 patients included in the study. Very good outcome at the 3rd month was detected in 80.1% of the patients with ENI, and in 15.6% of the patients without ENI (p<0.001). Patients with ENI were younger (p=0.025), and had lower NIHSS scores (p=0.027) and higher ASPECT scores (p=0.008) than those without. The ENI group had lower serum glucose levels at the time of admission (p< 0.001). Additionally, the presence of diabetes mellitus, hypertension, and hyperdense artery sign were more frequent in the ENI group (p=0.001, p=0.024, and p<0.001, respectively). Finally, multiple regression analysis showed a significant relationship between serum glucose level, hyperdense artery sign, and ENI. Conclusion: There is a significant relationship between ENI and very good outcome at 3 months in acute stroke patients who received IV rtPA. Therefore, the management of factors such as serum glucose level, NIHSS score, ASPECT score and presence of hyperdense artery sign which are related to ENI, and the determination of treatment strategies according to them are important issues for achieving a better outcome in acute ischemic stroke.

Özet

Amaç: Bu çalışmada, İntravenöz rekombinant doku plazminojen aktivatörü (İV rt-PA) ile tedavi edilen akut inme hastalarında erken nörolojik iyileşme (ENİ) ile ilişkili faktörleri ve ENİ’nin üç ay sonraki sonlanımla ilişkisini saptamak amaçlanmıştır. Yöntem: Eskişehir Osmangazi Üniversitesi Tıp Fakültesi inme merkezinde Şubat 2009 – Aralık 2016 tarihleri arasında ilk 4,5 saat içinde İV rt-PA uygulanan akut iskemik inmeli hastalar çalışmaya dahil edildi. ENİ, tedaviden 24 saat sonra National Institutes of Health Stroke Scale (NIHSS) skorunun 0 ya da 1 olması ya da tedavi öncesi skor ile karşılaştırıldığında ≥8 puanlık bir iyileşme olması olarak belirlendi. Hastaların tedavi sonrası 3. aydaki sonlanımları modified Rankin Scale (mRS) skoru ile belirlenmiş olup, mRS skoru 0–1 ise ‘çok iyi sonlanım’ olarak değerlendirildi. Bulgular: Çalışmaya dahil olan 355 hastanın %43,9’unda ENİ gözlendi. ENİ gözlenen hastaların %80,1’inde, gözlenmeyenlerinse %15,6’sında 3. ayda çok iyi sonlanım saptandı (p<0,001). ENİ gözlenen hastalar gözlenmeyenlere göre daha genç (p=0,025) olup, daha düşük NIHSS skorlarına (p=0,027) ve daha yüksek ASPECT skorlarına (p=0,008) sahipti. Yine, ENİ gözlenen grubun başvuru anındaki serum glukoz düzeyleri daha düşük olup (p<0,001), bu hastalarda diabetes mellitus ve hipertansiyon öyküsü ve hiperdens arter bulgusu saptanma oranı daha azdı (sırasıyla p=0,001, p=0,024 ve p<0,001). Son olarak; çoklu regresyon analizinde ise başvuru serum glukoz düzeyi ve hiperdens arter işareti ile ENİ arasında anlamlı ilişki saptandı. Sonuç: İV rt-PA uygulanan akut inme hastalarında, ENİ ve üç ay sonraki çok iyi sonlanım arasında anlamlı ilişki mevcuttur. Bu yüzden, özellikle ENİ ile ilişkisi saptanmış olan bir başvuruda, serum glukoz düzeyi, NIHSS skoru, ASPECT skoru ve hiperdens arter işareti varlığı gibi faktörlerin yönetimi ve tedavi stratejilerinin bunlara göre değerlendirmesi, akut iskemik inmede daha iyi bir sonlanımın sağlanması açısından önem taşımaktadır.

🔖

Cite This Article

ERYILDIZ, E. S., ÖZDEMİR, A. Ö. (2018). Factors Associated with Early Recovery after Intravenous Thrombolytic Therapy in Acute Ischemic Stroke. Nöropsikiyatri Arşivi, Cilt: 55 - Sayı: 1, 80–83. https://ajindex.com/articles/292235

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Truelsen T, Ekman M, Boysen G. Cost of stroke in Europe. Eur J Neurol 2005;12:78–84. [CrossRef] J Bogousslavsky, Liu M, Moncayo J, Norrving B, Tsiskaridze A, Yamaguchi T, Yatsu F. Neurological disorders; a public health approach, Chap 3.9. Stroke. In: Neurological disorders, Public Health Challenges. Switzerland: WHO Press; 2006. p.151–163.
  2. Fieschi C, Argentino C, Lenzi GL, Sacchetti ML, Toni D, Bozzao L. Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours. J Neuro Sci 1989;91:311–321. del Zoppo GJ, Poeck K, Pessin MS, Wolpert SM, Furlan AJ, Ferbert A, Alberts MJ, Zivin JA, Wechsler L, Busse O, Greenlee R Jr, Brass L, Mohr JP, Feldmann E, Hacke W, Kase CS, Biller J, Gress D, Otis SM. Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke. Ann Neurol 1992;32:78– 86. [CrossRef] National Institute of Neurological Disorders and Stroke tPA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995;333:1581–1587. [CrossRef] Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Walhlgren N, Toni D; ECASS Investigators. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008;359:1317–1329. [CrossRef] Brown DL, Johnston KC, Wagner DP, Haley EC Jr. Predicting major neurological improvement with intravenous recombinant tissue plasminogen activator treatment of stroke. Stroke 2004;35:147–150. [CrossRef] Johnston KC, Connors AF Jr, Wagner DP, Knaus WA, Wang X, Haley EC Jr. A predictive risk model for outcomes of ischemic stroke. Stroke 2000;31:448– 455. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008;25:457–507. [CrossRef] Mazya M, Egido JA, Ford GA, Lees KR, Mikulik R, Toni D, Wahlgren N, Ahmed N; SITS Investigators. Predicting the risk of symptomatic intracerebral hemorrhage in ischemic stroke treated with intravenous alteplase: safe Implementation of Treatments in Stroke (SITS) symptomatic intracerebral hemorrhage risk score. Stroke 2012;43:1524–1531. [CrossRef] Saposnik G, Di Legge S, Webster F, Hachinski V. Predictors of major neurologic improvement after thrombolysis in acute stroke. Neurology 2005;65:1169– 1174. [CrossRef] Demchuk AM, Burgin WS, Christou I, Felberg RA, Barber PA, Hill MD, Alexandrov AV. Thrombolysis